)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
PetVivo
PetVivo (PETV) investor relations material
PetVivo Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary20 Aug, 2026
Market opportunity and industry trends
US companion animal veterinary care and product sales market valued at $39.8B, with a historical CAGR of ~6% from 2020-2024.
Pet spending in the US rose from $152B in 2024 to $157B in 2025, with veterinary care as a key growth driver.
71% of US households own a pet, with increasing willingness to spend on pet health.
Pet health insurance market is rapidly expanding, with insured pets rising from 5.17M in 2024 to 6.4M in 2025.
Market is primed for innovative medical devices and therapeutics for companion animals.
Product innovation and pipeline
SpryngⓇ with OsteoCushionⓇ Technology is a veterinary device designed to restore joint mechanics and manage lameness and osteoarthritis.
Revivion™ is a next-generation platform combining collagen-elastin hydrogel microparticles with piezoelectric nanofibers for enhanced joint health.
Product pipeline includes devices for osteoarthritis, ocular care, wound care, respiratory indications, and drug delivery for canine, equine, and feline species.
Human product pipeline under development, requiring FDA clearance.
No FDA review required for commercialization of veterinary medical devices.
Clinical efficacy and safety
SpryngⓇ provides biocompatible, lubricious, and viscoelastic biomaterial, mimicking natural cartilage components.
Case studies and clinical trials show long-lasting improvement in lameness and joint function in dogs, cats, and horses.
Tolerance studies in dogs and cats demonstrated excellent safety profiles with no observed abnormalities.
Peer-reviewed studies indicate SpryngⓇ reduces inflammatory responses and supports joint health.
Over 15,000 animals have been successfully treated with SpryngⓇ.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PetVivo
- Revenue up 13% YoY, net loss narrowed, PBM and PetVivo.ai drive growth amid financing risks.PETV
Q1 2027 - Regulatory wins, AI launches, and PBM acquisition drive innovation amid higher losses.PETVQ4 2026
- Innovative joint health solutions, AI launch, and new tech acquisitions drive growth and expansion.PETVLife Sciences Virtual Investor Forum
- Spryng and PrecisePRP gain momentum as accessible, innovative joint health solutions for pets.PETVInvestor update
- SpryngⓇ delivers long-lasting, clinically proven joint relief, fueling growth in animal health.PETVCorporate presentation
- AI platform launches and global expansion offset by declining revenue and increased net loss.PETVQ3 2026
- Revenue up 141% year-over-year, net loss $2.3M, cash strengthened, but going concern risk remains.PETVQ1 2026
- Revenue up 6%, gross margin 89.5%, net loss narrows, but delisting and funding risks persist.PETVQ1 2025
- Q3 revenue surged 191% sequentially to $583,000, but ongoing capital needs persist.PETVQ3 2025
Next PetVivo earnings date
Q2 202720 Nov, 2026
PetVivo
Next PetVivo earnings date
Q2 202720 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
PetVivo Holdings, Inc. is a U.S.-based biomedical company specializing in the development and commercialization of innovative medical products for the companion animal market. The company’s product portfolio focuses on veterinary treatments that address osteoarthritis and other joint-related afflictions in dogs, horses, and other animals. PetVivo combines expertise in biomaterials and veterinary medicine to create solutions aimed at improving the quality of life for pets. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.